Clinical Research Directory
Browse clinical research sites, groups, and studies.
OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
Sponsor: Central Hospital, Nancy, France
Summary
This registry will make it possible to collect large-scale data on SAPL patients, particularly those treated with DOACs, in order to better assess the frequency of thrombotic and hemorrhagic events in this population of "non-high-risk" thrombotic SAPL patients treated with DOACs. The results will help refine treatment recommendations and could form the basis of future clinical trials. In this study, there will be no modification of the usual care and no additional follow-up. Follow-up will be carried out during the patient's usual visits in the context of his or her pathology, the frequency of which will be left to the discretion of the usual physician. No additional consultations/hospitalizations/examinations will be carried out as part of the study. Data normally recorded in the medical record will be collected over a 5-year period, in line with standard patient follow-up.
Official title: OBServaToIre National Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-07-01
Completion Date
2035-07-01
Last Updated
2025-04-20
Healthy Volunteers
No
Conditions
Interventions
"non-high risk" thrombotic APS patients treated with DOAC
There is no specific intervention in this study. Routine care data will be collected from patients with a 'non-high-risk' APS profile who are currently being treated with DOACs or have been in the past.
Locations (1)
Vall d´Hebron University Hospital
Barcelona, Spain